The Surge of Hypervirulent ST398 MRSA Lineage With Higher Biofilm-Forming Ability Is a Critical Threat to Clinics
Overview
Authors
Affiliations
The global increase of community-associated (CA) infections with methicillin-resistant (MRSA) is a major healthcare problem. Although sequence type (ST) 398 MRSA was first described as a livestock-associated (LA) lineage, human-adapted MRSA (HO-MRSA) ST398 without livestock contact has subsequently been reported from China in our previous study and other later research. The proportion of ST398 HO-MRSA has also remarkably increased in recent years in China. Based on 3878 isolates that were collected in a general hospital between 2008 and 2018, we identified 56 ST398 HO-MRSA isolates. The four early appearing isolates of them have been sequenced by whole-genome sequencing (WGS) in our previous study. Here, by usage of WGS on the later-appearing 52 isolates and analyzing the phylogenetic dynamics of the linage, we found that 50 isolates clustered together with the former 4 isolates, making it a main clade out of MSSA clones and other MRSA clones, although ST398 HO-MRSA evolved with multiple origins. Drug resistance and virulence gene analysis based on the WGS data demonstrated that ST398 HO-MRSA main clade exhibited a similar pattern in both parts. Furthermore, they all carried a conserved variant of prophage 3 to guarantee virulence and a short SCC type V element of class D to maintain considerable lower methicillin resistance. Further phenotypical research verified that the epidemic HO-MRSA ST398 displayed enhanced biofilm formation ability when keeping high virulence. The dual advantages of virulence and biofilm formation in the HO-MRSA ST398 subtype promote their fitness in the community and even in the healthcare environment, which poses a serious threat in clinical infections. Therefore, further surveillance is required to prevent and control the problematic public health impact of HO-MRSA ST398 in the future.
Dai C, Ji W, Zhang Y, Huang W, Wang H, Wang X Front Pediatr. 2024; 12:1457645.
PMID: 39483528 PMC: 11524809. DOI: 10.3389/fped.2024.1457645.
Jian Y, Chen T, Yang Z, Xiang G, Xu K, Wang Y Emerg Microbes Infect. 2024; 13(1):2341972.
PMID: 38597192 PMC: 11034457. DOI: 10.1080/22221751.2024.2341972.
Troeman D, Hazard D, Timbermont L, Malhotra-Kumar S, van Werkhoven C, Wolkewitz M JAMA Netw Open. 2023; 6(10):e2339793.
PMID: 37906196 PMC: 10618839. DOI: 10.1001/jamanetworkopen.2023.39793.
Multi-Host Pathogen -Epidemiology, Drug Resistance and Occurrence in Humans and Animals in Poland.
Troscianczyk A, Nowakiewicz A, Kasela M, Malm A, Tracz A, Hahaj-Siembida A Antibiotics (Basel). 2023; 12(7).
PMID: 37508233 PMC: 10376275. DOI: 10.3390/antibiotics12071137.
Panton-Valentine Leukocidin-Positive CC398 MRSA in Urban Clinical Settings, the Netherlands.
Gooskens J, Konstantinovski M, Kraakman M, Kalpoe J, van Burgel N, Claas E Emerg Infect Dis. 2023; 29(5):1055-1057.
PMID: 36913919 PMC: 10124631. DOI: 10.3201/eid2905.221717.